Optimune IBD

Manufacturer: Biomune

Bursal Disease Vaccine, Standard and Variants, Killed Virus

U.s. Vet. Lic. No.

368

Contents

OPTIMUNE^® IBD is an inactivated oil emulsion vaccine containing three infectious bursal disease viruses, the standard type and two variants. The viruses in OPTIMUNE^® IBD are noncloned isolates produced in chicken embryos or bursal tissue.

The vaccine has undergone rigid potency, safety and purity tests and meets Biomune and USDA requirements.

Optimune IBD Indications

The vaccine is intended for use in healthy breeder replacement chickens and breeder hens against disease caused by infectious bursal disease viruses or the standard and variant types. Breeder vaccination provides maternal antibody to the progeny of breeder hens for the prevention of early exposure to bursal disease.

Optimune IBD Dosage And Administration

A prime with live infectious bursal disease vaccine is recommended at least four (4) weeks in advance of administration of the inactivated vaccine.

Vaccinate chickens with 0.5 mL per bird. The vaccine is to be administered by the subcutaneous route in the back of the neck, midway between the head and the body, in a direction away from the head. Do not inject into muscle or vertebrae.

Refer to the product label for specific use directions and precautions.

Precaution(s)

Store the vaccine at 35°-45°F (2°-7°C). Do not freeze.

Warning(s)

Do not vaccinate with oil emulsion vaccine within 42 days before slaughter.

Avoid injection of the vaccine into a human. Should accidental injection of a human occur, seek medical attention immediately since a serious localized reaction may result.

Presentation

1,000 dose (500 mL) bottle.

Nac No.

11290232